$15.90
Price
$1.8B
Market Cap
—
P/E Ratio
-4.4
Forward P/E
$-4.25
EPS (TTM)
—
Dividend Yield
$511M
Cash
$210M
Total Debt
116M
Shares Out
$5.90
$28.25
52-Week Range
Institutional Ownership of INTELLIA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for INTELLIA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2023-Q2 | |||||
| SELL | EXIT | — | — | $40.98 | |
| 2023-Q1 | |||||
| SELL | -22.4% | 1.6M | $58M | $39.02 | |
| 2022-Q4 | |||||
| BUY | +7.0% | 2.0M | $71M | $49.53 | |
| 2022-Q3 | |||||
| SELL | -15.2% | 1.9M | $106M | $63.18 | |
| 2022-Q2 | |||||
| BUY | +74.2% | 2.2M | $115M | $49.03 | |
| 2022-Q1 | |||||
| SELL | -19.0% | 1.3M | $172M | $85.80 | |
| 2021-Q4 | |||||
| BUY | +23.4% | 1.6M | $187M | $128.08 | |
| 2021-Q3 | |||||
| BUY | +31.2% | 1.3M | $172M | $152.73 | |
| 2021-Q2 | |||||
| BUY | NEW | 975.1K | $158M | $73.77 | |
Insider Trading for INTELLIA THERAPEUTICS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.